Clinical Trial Update: Nasal Fentanyl and Buccal Midazolam for Dying Patients [Phase 4]

View source ↗

Summary

The study reports the completed Phase 4 trial examining nasal fentanyl and buccal midazolam for symptom management in terminal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Terminal Cancer

Drugs mentioned

• Buccal midazolam (midazolam)
• Nasal fentanyl (fentanyl)

Snippet

Sponsor: Gloucestershire Hospitals NHS Foundation Trust | Conditions: Terminal Cancer | Phase 4 | Status: COMPLETED